Home
RGEN
RGEN News

Latest Repligen Corporation (RGEN) News on October 20, 2025

Is Repligen’s Recent 18% Price Surge Justified After Broad Biotech Rally?

Simply Wall St.

16 days ago

Is Repligen’s Recent 18% Price Surge Justified After Broad Biotech Rally?

Why Is Repligen (RGEN) Stock Soaring Today

StockStory

19 days ago

Why Is Repligen (RGEN) Stock Soaring Today

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

StockStory

20 days ago

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

3 Reasons to Sell RGEN and 1 Stock to Buy Instead

StockStory

a month ago

3 Reasons to Sell RGEN and 1 Stock to Buy Instead

Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)

StockStory

a month ago

Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)

Three Stocks Estimated To Be Below Fair Value In September 2025

Simply Wall St.

a month ago

Three Stocks Estimated To Be Below Fair Value In September 2025

Repligen (RGEN) Stock Is Up, What You Need To Know

StockStory

a month ago

Repligen (RGEN) Stock Is Up, What You Need To Know

Why Repligen (RGEN) Stock Is Down Today

StockStory

a month ago

Why Repligen (RGEN) Stock Is Down Today

Newsfile

a month ago

Virgo Group to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

Does Voyager Technologies (VOYG) Have a Substantial Long-Term Upside?

Insider Monkey

a month ago

Does Voyager Technologies (VOYG) Have a Substantial Long-Term Upside?

Seed Oil Scout Announces 8 New Seed Oil Safe® Brands

PR Newswire

a month ago

Seed Oil Scout Announces 8 New Seed Oil Safe® Brands

Do You Believe in Comfort Systems USA’s (FIX) Ability to Outgrow the Market?

Insider Monkey

a month ago

Do You Believe in Comfort Systems USA’s (FIX) Ability to Outgrow the Market?

AutoTrust Dealer Alliance Launches to Return Millions in Profits and Equity to Dealers

PR Newswire

a month ago

AutoTrust Dealer Alliance Launches to Return Millions in Profits and Equity to Dealers

Business Wire

a month ago

Net Asset Value(s)

Crypto Streamer Crashes His Token, Says 'It Was Literally Just An Accidental Click'

Benzinga

a month ago

Crypto Streamer Crashes His Token, Says 'It Was Literally Just An Accidental Click'

Anglo American stock rises 9% after merger deal with Teck Resources

Euronews

a month ago

Anglo American stock rises 9% after merger deal with Teck Resources

Argus Research

4 months ago

RGEN: Raising target price to $99.00

5 Insightful Analyst Questions From Repligen’s Q1 Earnings Call

StockStory

4 months ago

5 Insightful Analyst Questions From Repligen’s Q1 Earnings Call

Argus Research

4 months ago

RGEN: Raising target price to $140.00

1 Unprofitable Stock for Long-Term Investors and 2 to Ignore

StockStory

4 months ago

1 Unprofitable Stock for Long-Term Investors and 2 to Ignore

Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025

Simply Wall St.

4 months ago

Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks

StockStory

4 months ago

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers

StockStory

5 months ago

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?

Zacks

5 months ago

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?

3 of Wall Street’s Favorite Stocks in Hot Water

StockStory

5 months ago

3 of Wall Street’s Favorite Stocks in Hot Water

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report?

Zacks

5 months ago

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report?

Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report

GlobeNewswire

5 months ago

Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report

Repligen Corporation to Present at William Blair Growth Conference

GlobeNewswire

5 months ago

Repligen Corporation to Present at William Blair Growth Conference

MT Newswires

5 months ago

Repligen Insider Sold Shares Worth $3,271,688, According to a Recent SEC Filing

Argus Research

5 months ago

RGEN: Raising target price to $138.00

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

StockStory

5 months ago

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar

StockStory

5 months ago

1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar

Repligen Corporation to Present at Upcoming May Investor Conferences

GlobeNewswire

5 months ago

Repligen Corporation to Present at Upcoming May Investor Conferences

Argus Research

5 months ago

RGEN: Lowering target price to $137.00

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare

Insider Monkey

6 months ago

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’

Insider Monkey

6 months ago

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’

Insider Monkey

6 months ago

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’

RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty

StockStory

6 months ago

RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty

Morningstar Research

6 months ago

Analyst Report: Repligen Corporation

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y

Zacks

6 months ago

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y

MT Newswires

6 months ago

RBC Lowers Price Target on Repligen to $189 From $202, Keeps Outperform Rating

Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

6 months ago

Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Repligen Corp Earnings Call

MT Newswires

6 months ago

Wolfe Research Upgrades Repligen to Outperform From Peerperform

Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates

Zacks

6 months ago

Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations

StockStory

6 months ago

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations

StockStory

6 months ago

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations

MT Newswires

6 months ago

Repligen's Q1 Adjusted Earnings, Revenue Rise; Trims 2025 Adjusted Earnings, Raises Revenue Guidance

Associated Press Finance

6 months ago

Repligen: Q1 Earnings Snapshot

Repligen Reports First Quarter 2025 Financial Results

GlobeNewswire

6 months ago

Repligen Reports First Quarter 2025 Financial Results

What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings

GuruFocus.com

6 months ago

What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings

Repligen (RGEN) Q1 Earnings: What To Expect

StockStory

6 months ago

Repligen (RGEN) Q1 Earnings: What To Expect

3 Healthcare Stocks That Concern Us

StockStory

6 months ago

3 Healthcare Stocks That Concern Us

Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?

Zacks

6 months ago

Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?

Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline

Zacks

6 months ago

Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline

Argus Research

6 months ago

RGEN: Rating decreased to a SELL

Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

6 months ago

Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth

Three Stocks That May Be Undervalued In April 2025

Simply Wall St.

6 months ago

Three Stocks That May Be Undervalued In April 2025

GMAB or RGEN: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

GMAB or RGEN: Which Is the Better Value Stock Right Now?

Argus Research

6 months ago

RGEN: Raising target price to $133.00

Repligen to Report First Quarter 2025 Financial Results

GlobeNewswire

6 months ago

Repligen to Report First Quarter 2025 Financial Results

Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings?

StockStory

6 months ago

Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings?

Argus Research

6 months ago

RGEN: Lowering target price to $114.00

Repligen Appoints Jacob Johnson As Vice President Investor Relations

GlobeNewswire

6 months ago

Repligen Appoints Jacob Johnson As Vice President Investor Relations

MT Newswires

6 months ago

RBC Cuts Price Target on Repligen to $202 From $219, Keeps Outperform Rating

Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?

Zacks

6 months ago

Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?

Argus Research

7 months ago

RGEN: Lowering target price to $135.00

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

StockStory

7 months ago

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

Argus Research

7 months ago

RGEN: Lowering target price to $149.00

Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management?

Insider Monkey

7 months ago

Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management?

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

StockStory

7 months ago

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?

Zacks

7 months ago

Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?

MT Newswires

7 months ago

Evercore ISI Initiates Repligen at In Line With $155 Price Target

Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks

StockStory

7 months ago

Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

StockStory

7 months ago

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

StockStory

7 months ago

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

Morningstar Research

7 months ago

Analyst Report: Repligen Corporation

3 Small-Cap Stocks Skating on Thin Ice

StockStory

7 months ago

3 Small-Cap Stocks Skating on Thin Ice

Thomson Reuters StreetEvents

8 months ago

Q4 2024 908 Devices Inc. Earnings Call

Argus Research

8 months ago

RGEN: Lowering target price to $163.00

MT Newswires

8 months ago

Top Midday Gainers

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

Benzinga

8 months ago

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

MT Newswires

8 months ago

Repligen Buys 908 Devices' Desktop Portfolio for $70 Million

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

GlobeNewswire

8 months ago

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

Argus Research

8 months ago

RGEN: Raising target price to $170.00

Morningstar Research

8 months ago

Analyst Report: Repligen Corporation

Repligen's Q4 Earnings Beat Estimates, Revenues In Line

Zacks

8 months ago

Repligen's Q4 Earnings Beat Estimates, Revenues In Line

MT Newswires

8 months ago

RBC Raises Price Target on Repligen to $205 From $203, Keeps Outperform Rating

MT Newswires

8 months ago

Deutsche Bank Adjusts Repligen Price Target to $195 From $190, Maintains Buy Rating

Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

8 months ago

Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Repligen Corp Earnings Call

Morningstar Research

8 months ago

Analyst Report: Repligen Corporation

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

Benzinga

8 months ago

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

February 2025's US Stocks That May Be Trading Below Fair Value

Simply Wall St.

8 months ago

February 2025's US Stocks That May Be Trading Below Fair Value

What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings

GuruFocus.com

8 months ago

What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings

Repligen (RGEN) Beats Q4 Earnings Estimates

Zacks

8 months ago

Repligen (RGEN) Beats Q4 Earnings Estimates

Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates

StockStory

8 months ago

Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates

Associated Press Finance

8 months ago

Repligen: Q4 Earnings Snapshot

MT Newswires

8 months ago

Repligen Q4 Adjusted Earnings Decline, Revenue Increases -- Shares Up Pre-Bell

Share on Social Networks: